RecruitingPhase 3NCT07210515

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Studying Complex regional pain syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ambros Therapeutics, Inc.
Intervention
Neridronate(drug)
Enrollment
270 enrolled
Eligibility
18 years · All sexes
Timeline
20262028

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07210515 on ClinicalTrials.gov

Other trials for Complex regional pain syndrome

Additional recruiting or active studies for the same condition.

See all trials for Complex regional pain syndrome

← Back to all trials